TAAR1 Expression in Human Macrophages and Brain Tissue: A Potential Novel Facet of MS Neuroinflammation

TAAR1 is a neuroregulator with emerging evidence suggesting a role in immunomodulation. Multiple sclerosis (MS) is an immune-mediated demyelinating disease of the central nervous system. Here, we investigate TAAR1 expression in human primary monocytes, peripherally-derived macrophages, and MS brain...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: David A. Barnes, Dylan A. Galloway, Marius C. Hoener, Mark D. Berry, Craig S. Moore
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/400c40f3545e4f048a4d3ac2d8e6195f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:400c40f3545e4f048a4d3ac2d8e6195f
record_format dspace
spelling oai:doaj.org-article:400c40f3545e4f048a4d3ac2d8e6195f2021-11-11T17:03:33ZTAAR1 Expression in Human Macrophages and Brain Tissue: A Potential Novel Facet of MS Neuroinflammation10.3390/ijms2221115761422-00671661-6596https://doaj.org/article/400c40f3545e4f048a4d3ac2d8e6195f2021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11576https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067TAAR1 is a neuroregulator with emerging evidence suggesting a role in immunomodulation. Multiple sclerosis (MS) is an immune-mediated demyelinating disease of the central nervous system. Here, we investigate TAAR1 expression in human primary monocytes, peripherally-derived macrophages, and MS brain tissue. RT-qPCR was used to assess TAAR1 levels in MS monocytes. Using a previously validated anti-human TAAR1 antibody and fluorescence microscopy, TAAR1 protein was visualized in lipopolysaccharide-stimulated or basal human macrophages, as well as macrophage/microglia populations surrounding, bordering, and within a mixed active/inactive MS lesion. In vivo, TAAR1 mRNA expression was significantly lower in MS monocytes compared to age- and sex-matched healthy controls. In vitro, TAAR1 protein showed a predominant nuclear localization in quiescent/control macrophages with a shift to a diffuse intracellular distribution following lipopolysaccharide-induced activation. In brain tissue, TAAR1 protein was predominantly expressed in macrophages/microglia within the border region of mixed active/inactive MS lesions. Considering that TAAR1-mediated anti-inflammatory effects have been previously reported, decreased mRNA in MS patients suggests possible pathophysiologic relevance. A shift in TAAR1 localization following pro-inflammatory activation suggests its function is altered in pro-inflammatory states, while TAAR1-expressing macrophages/microglia bordering an MS lesion supports TAAR1 as a novel pharmacological target in cells directly implicated in MS neuroinflammation.David A. BarnesDylan A. GallowayMarius C. HoenerMark D. BerryCraig S. MooreMDPI AGarticlemultiple sclerosistrace aminestrace amine-associated receptor 1neuroinflammationBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11576, p 11576 (2021)
institution DOAJ
collection DOAJ
language EN
topic multiple sclerosis
trace amines
trace amine-associated receptor 1
neuroinflammation
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle multiple sclerosis
trace amines
trace amine-associated receptor 1
neuroinflammation
Biology (General)
QH301-705.5
Chemistry
QD1-999
David A. Barnes
Dylan A. Galloway
Marius C. Hoener
Mark D. Berry
Craig S. Moore
TAAR1 Expression in Human Macrophages and Brain Tissue: A Potential Novel Facet of MS Neuroinflammation
description TAAR1 is a neuroregulator with emerging evidence suggesting a role in immunomodulation. Multiple sclerosis (MS) is an immune-mediated demyelinating disease of the central nervous system. Here, we investigate TAAR1 expression in human primary monocytes, peripherally-derived macrophages, and MS brain tissue. RT-qPCR was used to assess TAAR1 levels in MS monocytes. Using a previously validated anti-human TAAR1 antibody and fluorescence microscopy, TAAR1 protein was visualized in lipopolysaccharide-stimulated or basal human macrophages, as well as macrophage/microglia populations surrounding, bordering, and within a mixed active/inactive MS lesion. In vivo, TAAR1 mRNA expression was significantly lower in MS monocytes compared to age- and sex-matched healthy controls. In vitro, TAAR1 protein showed a predominant nuclear localization in quiescent/control macrophages with a shift to a diffuse intracellular distribution following lipopolysaccharide-induced activation. In brain tissue, TAAR1 protein was predominantly expressed in macrophages/microglia within the border region of mixed active/inactive MS lesions. Considering that TAAR1-mediated anti-inflammatory effects have been previously reported, decreased mRNA in MS patients suggests possible pathophysiologic relevance. A shift in TAAR1 localization following pro-inflammatory activation suggests its function is altered in pro-inflammatory states, while TAAR1-expressing macrophages/microglia bordering an MS lesion supports TAAR1 as a novel pharmacological target in cells directly implicated in MS neuroinflammation.
format article
author David A. Barnes
Dylan A. Galloway
Marius C. Hoener
Mark D. Berry
Craig S. Moore
author_facet David A. Barnes
Dylan A. Galloway
Marius C. Hoener
Mark D. Berry
Craig S. Moore
author_sort David A. Barnes
title TAAR1 Expression in Human Macrophages and Brain Tissue: A Potential Novel Facet of MS Neuroinflammation
title_short TAAR1 Expression in Human Macrophages and Brain Tissue: A Potential Novel Facet of MS Neuroinflammation
title_full TAAR1 Expression in Human Macrophages and Brain Tissue: A Potential Novel Facet of MS Neuroinflammation
title_fullStr TAAR1 Expression in Human Macrophages and Brain Tissue: A Potential Novel Facet of MS Neuroinflammation
title_full_unstemmed TAAR1 Expression in Human Macrophages and Brain Tissue: A Potential Novel Facet of MS Neuroinflammation
title_sort taar1 expression in human macrophages and brain tissue: a potential novel facet of ms neuroinflammation
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/400c40f3545e4f048a4d3ac2d8e6195f
work_keys_str_mv AT davidabarnes taar1expressioninhumanmacrophagesandbraintissueapotentialnovelfacetofmsneuroinflammation
AT dylanagalloway taar1expressioninhumanmacrophagesandbraintissueapotentialnovelfacetofmsneuroinflammation
AT mariuschoener taar1expressioninhumanmacrophagesandbraintissueapotentialnovelfacetofmsneuroinflammation
AT markdberry taar1expressioninhumanmacrophagesandbraintissueapotentialnovelfacetofmsneuroinflammation
AT craigsmoore taar1expressioninhumanmacrophagesandbraintissueapotentialnovelfacetofmsneuroinflammation
_version_ 1718432172457590784